Thoratec Laboratories gets Japanese approval for vascular access graft:
This article was originally published in Clinica
Executive Summary
Thoratec Laboratories has received approval from the Japanese Ministry of Health to market its vascular access graft in Japan. The graft is designed as a permanent needle access to patients undergoing renal dialysis and will be marketed by the Californian company's distributor Goodman.